5 Insightful Analyst Questions From Medifast's Q3 Earnings Call [Yahoo! Finance]
MEDIFAST INC (MED)
Last medifast inc earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.medifastnow.com
Company Research
Source: Yahoo! Finance
Management attributed these results to ongoing headwinds in the weight loss industry—most notably, increased competition from GLP-1 medications and declines in the number of active earning coaches. CEO Dan Chard highlighted that the company's evolving science-backed approach to metabolic health aims to differentiate Medifast in a changing landscape. Chard pointed to coach-led support and recent clinical studies as key elements, while also acknowledging the need for further progress in reversing declining sales. Is now the time to buy MED? Find out in our full research report (it's free for active Edge members). Medifast (MED) Q3 CY2025 Highlights: Revenue: $89.41 million vs analyst estimates of $89.7 million (36.2% year-on-year decline, in line) EPS (GAAP): -$0.21 vs analyst estimates of -$0.36 (41.7% beat) Adjusted EBITDA: -$2.22 million vs analyst estimates of -$4.1 million (-2.5% margin, 45.9% beat) Revenue Guidance for Q4 CY2025 is $72.5 million at the midpoint, below
Show less
Read more
Impact Snapshot
Event Time:
MED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MED alerts
High impacting MEDIFAST INC news events
Weekly update
A roundup of the hottest topics
MED
News
- Medifast: Between Obsolescence And Optionality [Seeking Alpha]Seeking Alpha
- MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges [Yahoo! Finance]Yahoo! Finance
- Medifast Announces Third Quarter 2025 Financial ResultsBusiness Wire
- Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™Business Wire
- Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025Business Wire
MED
Earnings
- 11/3/25 - Miss
MED
Sec Filings
- 11/13/25 - Form SCHEDULE
- 11/3/25 - Form 10-Q
- 11/3/25 - Form 8-K
- MED's page on the SEC website